Interfacial cfDNA Enrichment and Amplification with On‐Chip Thermoplasmonics for Highly Sensitive Cancerous Liquid Biopsy
Advanced Science · 2025
DOI: 10.1002/advs.202409708 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Danhua Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Biomarkers, Tumor, Biosensing Techniques, Circulating Tumor DNA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Tumor‐derived cell‐free DNA (cfDNA) has been exploited as an effective liquid biopsy biomarker for early cancer diagnosis. However, the fragmented and low‐abundance nature in circulating blood pose challenges for highly sensitive cfDNA quantification. Herein, a multifunctional plasmonic biosensor termed Interfacial cfDNA Enrichment, Amplification and Sensing with on‐chip Thermoplasmonics (INEAST) is developed for cfDNA‐based liquid biopsy and lung cancer diagnosis. The INEAST biosensor achieved in situ thermoregulation and label‐free cfDNA biosensing by simultaneously harnessing interfacial thermoplasmonics and localized surface plasmon resonance. Typical cfDNA biomarkers, including epidermal growth factor receptor ( EGFR) , tumor protein 53 ( TP53) , phosphatase and tensin homologue deleted on chromosome 10 ( PTEN) , and cyclin‐dependent kinase inhibitor ( CDKN2A) , are quantified with detection limits down to femtomolar‐level. Through further validation using blood samples from lung cancer patients, the proposed INEAST bioassays demonstrated superior reliability for lung cancer screening, particularly when combined with clinically available tumor‐protein metrics. This study demonstrated that the INEAST biosensor enables rapid and sensitive cfDNA quantification, yielding a promising and compatible liquid biopsy for early‐stage lung cancer diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
- Department of Laboratory Medicine, Huadong Hospital Affiliated to Fudan University, Shanghai, 200031, China.
- The First People's Hospital of Linping District, Hangzhou, Zhejiang Province, 311100, China.
ORCID-Profile: Guangyu Qiu
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities
- Shanghai Municipal Science and Technology Major Project
Zitieren
APA
Wang, D., Liu, L., Chi, W., Liu, Z., Wu, J., Liang, Y., He, F., Zhang, R., Huang, P., Li, Y., & Qiu, G. (2025). Interfacial cfDNA Enrichment and Amplification with On‐Chip Thermoplasmonics for Highly Sensitive Cancerous Liquid Biopsy. Advanced Science. https://doi.org/10.1002/advs.202409708
Vancouver
Wang D, Liu L, Chi W, Liu Z, Wu J, Liang Y, et al. Interfacial cfDNA Enrichment and Amplification with On‐Chip Thermoplasmonics for Highly Sensitive Cancerous Liquid Biopsy. Advanced Science. 2025. doi:10.1002/advs.202409708
BibTeX
@article{Wang2025,
author = {Wang, Danhua and Liu, Linlin and Chi, Wenjing and Liu, Zhenping and Wu, Jiayun and Liang, Yirou and He, Fei and Zhang, Ruixiang and Huang, Pengxin and Li, Yunbo and Qiu, Guangyu},
title = {Interfacial cfDNA Enrichment and Amplification with On‐Chip Thermoplasmonics for Highly Sensitive Cancerous Liquid Biopsy},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202409708}
}
EUVIMED